Positioning the new drugs for migraine
Silvia Benemei(Azienda Ospedaliero-Universitaria Careggi), Paolo Martelletti(Unitelma Sapienza University), Enrico Bentivegna(Azienda Ospedaliera Sant'Andrea)
Cited by 14
Related Papers
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells
|Scientific Reports|2017|176
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|169
Long COVID headache
|The Journal of Headache and Pain|2022|158
Functional connectivity studies in migraine: what have we learned?
|The Journal of Headache and Pain|2019|107
TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities
|Pharmaceuticals|2019|104